|
1
|
Triplitt CL: Examining the mechanisms of
glucose regulation. Am J Manag Care. 18 (Suppl 1):S4–S10.
2012.PubMed/NCBI
|
|
2
|
Chatterjee S, Khunti K and Davies MJ: Type
2 diabetes. Lancet. 389:2239–2251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Petersen MC and Shulman GI: Mechanisms of
insulin action and insulin resistance. Physiol Rev. 98:2133–2223.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chan JC, Malik V, Jia W, Kadowaki T,
Yajnik CS, Yoon KH and Hu FB: Diabetes in Asia: Epidemiology, risk
factors, and pathophysiology. JAMA. 301:2129–2140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Riddy DM, Delerive P, Summers RJ, Sexton
PM and Langmead CJ: G Protein-coupled receptors targeting insulin
resistance, obesity, and type 2 diabetes mellitus. Pharmacol Rev.
70:39–67. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li G, Zhou F, Chen Y, Zhang W and Wang N:
Kukoamine A attenuates insulin resistance and fatty liver through
downregulation of Srebp-1c. Biomed Pharmacother. 89:536–543. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
von Horn C and Minor T: Modern concepts
for the dynamic preservation of the liver and kidneys in the
context of transplantation. Pathologe. 40:292–298. 2019.(In
German). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
El-Serag HB, Hampel H and Javadi F: The
association between diabetes and hepatocellular carcinoma: a
systematic review of epidemiologic evidence. Clin Gastroenterol
Hepatol. 4:369–380. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Polesel J, Zucchetto A, Montella M, Dal
Maso L, Crispo A, La Vecchia C, Serraino D, Franceschi S and
Talamini R: The impact of obesity and diabetes mellitus on the risk
of hepatocellular carcinoma. Ann Oncol. 20:353–357. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ueki T, Kaneda Y, Tsutsui H, Nakanishi K,
Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto
E, et al: Hepatocyte growth factor gene therapy of liver cirrhosis
in rats. Nat Med. 5:226–230. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fafalios A, Ma J, Tan X, Stoops J, Luo J,
Defrances MC and Zarnegar R: A hepatocyte growth factor receptor
(Met)-insulin receptor hybrid governs hepatic glucose metabolism.
Nat Med. 17:1577–1584. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang YY, Li C, Yao GF, Du LJ, Liu Y,
Zheng XJ, Yan S, Sun JY, Liu Y, Liu MZ, et al: Deletion of
Macrophage Mineralocorticoid Receptor Protects Hepatic Steatosis
and Insulin Resistance Through ERα/HGF/Met Pathway. Diabetes.
66:1535–1547. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oliveira AG, Araújo TG, Carvalho BM, Rocha
GZ, Santos A and Saad MJ: The role of hepatocyte growth factor
(HGF) in insulin resistance and diabetes. Front Endocrinol
(Lausanne). 9:5032018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Z, Xu R and Li N: MicroRNAs from plants
to animals, do they define a new messenger for communication? Nutr
Metab (Lond). 15:682018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Reinhart BJ, Weinstein EG, Rhoades MW,
Bartel B and Bartel DP: MicroRNAs in plants. Genes Dev.
16:1616–1626. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nicolai S, Pieraccioli M, Smirnov A,
Pitolli C, Anemona L, Mauriello A, Candi E,
Annicchiarico-Petruzzelli M, Shi Y, Wang Y, et al: ZNF281/Zfp281 is
a target of miR-1 and counteracts muscle differentiation. Mol
Oncol. 14:294–308. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fischer C, Seki T, Lim S, Nakamura M,
Andersson P, Yang Y, Honek J, Wang Y, Gao Y, Chen F, et al: A
miR-327-FGF10-FGFR2-mediated autocrine signaling mechanism controls
white fat browning. Nat Commun. 8:20792017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Trajkovski M, Hausser J, Soutschek J, Bhat
B, Akin A, Zavolan M, Heim MH and Stoffel M: MicroRNAs 103 and 107
regulate insulin sensitivity. Nature. 474:649–653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pardo F, Villalobos-Labra R, Sobrevia B,
Toledo F and Sobrevia L: Extracellular vesicles in obesity and
diabetes mellitus. Mol Aspects Med. 60:81–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thurnherr T, Mah WC, Lei Z, Jin Y, Rozen
SG and Lee CG: Differentially expressed miRNAs in hepatocellular
carcinoma target genes in the genetic information processing and
metabolism pathways. Sci Rep. 6:200652016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Liao Z, Bai Z, He Y, Duan J and
Wei L: MiR-93-5p Promotes cell proliferation through
down-regulating PPARGC1A in hepatocellular carcinoma cells by
bioinformatics analysis and experimental verification. Genes
(Basel). 9:92018. View Article : Google Scholar
|
|
23
|
Aravinthan A, Challis B, Shannon N, Hoare
M, Heaney J and Alexander GJ: Selective insulin resistance in
hepatocyte senescence. Exp Cell Res. 331:38–45. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Williams JF and Olefsky JM: Defective
insulin receptor function in down-regulated HepG2 cells.
Endocrinology. 127:1706–1717. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang H, Huo X, Yang XR, He J, Cheng L,
Wang N, Deng X, Jin H, Wang N, Wang C, et al: STAT3-mediated
upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer
metastasis by regulating SOX4. Mol Cancer. 16:1362017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Darpolor MM, Basu SS, Worth A, Nelson DS,
Clarke-Katzenberg RH, Glickson JD, Kaplan DE and Blair IA: The
aspartate metabolism pathway is differentiable in human
hepatocellular carcinoma: Transcriptomics and (13) C-isotope based
metabolomics. NMR Biomed. 27:381–389. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schmidt JA, Avarbock MR, Tobias JW and
Brinster RL: Identification of glial cell line-derived neurotrophic
factor-regulated genes important for spermatogonial stem cell
self-renewal in the rat. Biol Reprod. 81:56–66. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu HR, Yu XN, Zhang GC, Shi X,
Bilegsaikhan E, Guo HY, Liu LL, Cai Y, Song GQ, Liu TT, et al:
Comprehensive analysis of long non coding RNA messenger RNA
microRNA co expression network identifies cell cycle related lncRNA
in hepatocellular carcinoma. Int J Mol Med. 44:1844–1854.
2019.PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsai S, Clemente-Casares X, Zhou AC, Lei
H, Ahn JJ, Chan YT, Choi O, Luck H, Woo M, Dunn SE, et al: Insulin
Receptor-Mediated Stimulation Boosts T Cell Immunity during
Inflammation and Infection. Cell Metab. 28:922–934.e4. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mantovani A and Targher G: Type 2 diabetes
mellitus and risk of hepatocellular carcinoma: Spotlight on
nonalcoholic fatty liver disease. Ann Transl Med. 5:2702017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sim WJ, Iyengar PV, Lama D, Lui SKL, Ng
HC, Haviv-Shapira L, Domany E, Kappei D, Tan TZ, Saei A, et al:
c-Met activation leads to the establishment of a TGFβ-receptor
regulatory network in bladder cancer progression. Nat Commun.
10:43492019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hartmann S, Bhola NE and Grandis JR:
HGF/Met Signaling in head and neck cancer: Impact on the tumor
microenvironment. Clin Cancer Res. 22:4005–4013. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Boromand N, Hasanzadeh M, ShahidSales S,
Farazestanian M, Gharib M, Fiuji H, Behboodi N, Ghobadi N,
Hassanian SM, Ferns GA, et al: Clinical and prognostic value of the
C-Met/HGF signaling pathway in cervical cancer. J Cell Physiol.
233:4490–4496. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Coudriet GM, Stoops J, Orr AV, Bhushan B,
Koral K, Lee S, Previte DM, Dong HH, Michalopoulos GK, Mars WM, et
al: A noncanonical role for plasminogen activator inhibitor type 1
in obesity-induced diabetes. Am J Pathol. 189:1413–1422. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Muratsu J, Iwabayashi M, Sanada F,
Taniyama Y, Otsu R, Rakugi H and Morishita R: Hepatocyte growth
factor prevented high-fat diet-induced obesity and improved insulin
resistance in mice. Sci Rep. 7:1302017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bertola A, Bonnafous S, Cormont M, Anty R,
Tanti JF, Tran A, Le Marchand -Brustel Y and Gual P: Hepatocyte
growth factor induces glucose uptake in 3T3-L1 adipocytes through A
Gab1/phosphatidylinositol 3-kinase/Glut4 pathway. J Biol Chem.
282:10325–10332. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma DH, Li BS, Liu JJ, Xiao YF, Yong X,
Wang SM, Wu YY, Zhu HB, Wang DX and Yang SM: miR-93-5p/IFNAR1 axis
promotes gastric cancer metastasis through activating the STAT3
signaling pathway. Cancer Lett. 408:23–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang W, Yang Y, Wu J, Niu Y, Yao Y, Zhang
J, Huang X, Liang S, Chen R, Chen S, et al: Circular RNA cESRP1
sensitises small cell lung cancer cells to chemotherapy by sponging
miR-93-5p to inhibit TGF-β signalling. Cell Death Differ.
27:1709–1727. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang S, He Y, Liu C, Li G, Lu S, Jing Q,
Chen X, Ma H, Zhang D, Wang Y, et al: miR-93-5p enhances migration
and invasion by targeting RGMB in squamous cell carcinoma of the
head and neck. J Cancer. 11:3871–3881. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen C, Zheng Q, Kang W and Yu C: Long
non-coding RNA LINC00472 suppresses hepatocellular carcinoma cell
proliferation, migration and invasion through miR-93-5p/PDCD4
pathway. Clin Res Hepatol Gastroenterol. 43:436–445. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vauthey JN, Lauwers GY, Esnaola NF, Do KA,
Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A,
et al: Simplified staging for hepatocellular carcinoma. J Clin
Oncol. 20:1527–1536. 2002. View Article : Google Scholar : PubMed/NCBI
|
